Depletion of polyfunctional CD26<sup>high</sup>CD8<sup>+</sup> T cells repertoire in chronic lymphocytic leukemia.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics and consent to participateThis study was reviewed and approved by the Health Research Ethics Board of Alberta, Cancer Committee (HREBA#CC-17-0307). All participants provided informed written consent to participate in this study. Moreover, animal studies were approved by the animal ethics board at the University of Alberta with the protocol number AUP0001021. Consent for publicationAll authors consented to publish the study. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
"Funding This study was supported by the Canadian Institute for Health Research (CIHR) through a Foundation Grant and an operating grant from the Cancer Research Society (both to SE). Nevertheless, the funding bodies had no role in the design of the study, data collection, analysis and publication."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025